Drug Type Small molecule drug |
Synonyms- |
Mechanism p300-CBP transcription factors inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H22N4O2 |
InChIKeyFKQOEFTVOPIHMO-UHFFFAOYSA-N |
CAS Registry2447559-21-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Leukemia | Preclinical | CN | 01 Aug 2020 | |
Leukemia | Preclinical | CN | 01 Aug 2020 | |
Prostatic Cancer | Preclinical | CN | 01 Aug 2020 | |
Prostatic Cancer | Preclinical | CN | 01 Aug 2020 |